Literature DB >> 22311116

Anticoagulation in neurointerventions: basic pharmacology and pathophysiology, current status, practical advice.

J Scharf1, C-E Dempfle.   

Abstract

This article gives an overview of anticoagulative medication accompanying neurointerventional procedures. The basic pharmacology of prevalent medication is outlined and the thrombogenicity of standard procedures is described. A brief overview of the literature on risks and benefits of standard medications and their monitoring is provided. A customized regime of care is presented.

Mesh：

Substances：

Year:  2012        PMID： 22311116     DOI： 10.1007/s00062-012-0133-6

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN： 1869-1439            Impact factor:   3.649


  52 in total

1.  Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarction.

Authors:  Renicus S Hermanides; Jan Paul Ottervanger; Jan-Henk E Dambrink; Menko-Jan de Boer; Jan C A Hoorntje; A T Marcel Gosselink; Harry Suryapranata; Felix Zijlstra; Arnoud W J van 't Hof
Journal:  Thromb Haemost       Date:  2011-08-11       Impact factor: 5.249

2.  Endothelialization of nonapposed stent struts located over the origin of a side branch: results with different carbofilm-coated stents.

Authors:  Armando Perez De Prado; Claudia Perez Martinez; Carlos Cuellas Ramon; J Manuel Gonzalo Orden; Jose R Altonaga; Maria J Garcia Iglesias; Marta Regueiro Purriños; M Asuncion Orden; Juan F Garcia Marin; Felipe Fernandez-Vazquez
Journal:  J Interv Cardiol       Date:  2009-03-13       Impact factor: 2.279

3.  Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study.

Authors:  M Bendszus; M Koltzenburg; R Burger; M Warmuth-Metz; E Hofmann; L Solymosi
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

4.  The distribution and size of ischemic lesions after carotid artery angioplasty and stenting: evidence for microembolization to terminal arteries.

Authors:  Lei Zhu; Max Wintermark; David Saloner; Madison Fandel; Xian Mang Pan; Joseph H Rapp
Journal:  J Vasc Surg       Date:  2011-01-07       Impact factor: 4.268

5.  The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.

Authors:  Shinichiro Uchiyama; Yasuo Ikeda; Yasuhisa Urano; Yoshiharu Horie; Takenori Yamaguchi
Journal:  Cerebrovasc Dis       Date:  2011-04-19       Impact factor: 2.762

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.

Authors:  Herbert D Aronow; Gregory Hess; Jerrold Hill; Andreas Kuznik; Larry Z Liu
Journal:  Am J Ther       Date:  2010 Mar-Apr       Impact factor: 2.688

Review 8.  Prevention and treatment of thromboembolism during endovascular aneurysm therapy.

Authors:  Jens Fiehler; Thorsten Ries
Journal:  Klin Neuroradiol       Date:  2009-05-15

9.  Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience.

Authors:  D H Lee; A Arat; H Morsi; H Shaltoni; J R Harris; M E Mawad
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-15       Impact factor: 3.825

Review 10.  Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

Authors:  Jawed Fareed; Debra A Hoppensteadt; Daniel Fareed; Muzaffer Demir; Rakesh Wahi; Melaine Clarke; Cafer Adiguzel; Rodger Bick
Journal:  Semin Thromb Hemost       Date:  2008-02       Impact factor: 4.180
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.